Inactive Instrument
Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Stocks
BLCM
US0794814048
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.76M 1.6M 1.48M 1.34M 2.52M 165M 2.62M 17.83M 7.05M 88.98M 6.62M 6.48M 281M | P/E 2021 |
-1.77x | P/E 2022 | -0.89x |
|---|---|---|---|---|---|
| Enterprise Value | -20.07M -18.22M -16.83M -15.19M -28.67M -1.88B -29.77M -203M -80.22M -1.01B -75.31M -73.72M -3.2B | EV / Sales 2021 |
-5.43x | EV / Sales 2022 | -10.4x |
| Free-Float |
98.45% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -6.68% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Maggio
CEO | Chief Executive Officer | 66 | 23/02/2024 |
Richard Fair
CEO | Chief Executive Officer | 57 | 31/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Fair
BRD | Director/Board Member | 57 | - |
Judith Kilmovsky
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.68% | -18.17% | - | - | 822K | ||
| +1.15% | -2.81% | +55.79% | +71.12% | 66.37B | ||
| +1.62% | -0.69% | +10.25% | +92.90% | 58.86B | ||
| +1.18% | +1.05% | +26.72% | +87.74% | 55.22B | ||
| +0.48% | -2.53% | +9.73% | +121.14% | 47.21B | ||
| -2.69% | -6.38% | +19.19% | +25.79% | 42.45B | ||
| -0.70% | +4.93% | +17.77% | +45.03% | 36.44B | ||
| -2.50% | -15.73% | +135.31% | +662.73% | 35.19B | ||
| +0.30% | -1.35% | +83.35% | +58.24% | 32.66B | ||
| -0.83% | +1.98% | -38.27% | +390.98% | 26.73B | ||
| Average | -1.15% | -2.29% | +35.54% | +172.85% | 45B | |
| Weighted average by Cap. | -0.28% | -2.18% | +35.31% | +147.49% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 6.2M 5.63M 5.2M 4.69M 8.85M 579M 9.19M 62.65M 24.78M 313M 23.26M 22.77M 988M | 1.5M 1.36M 1.26M 1.13M 2.14M 140M 2.22M 15.16M 6M 75.62M 5.63M 5.51M 239M |
| Net income | -9.7M -8.81M -8.14M -7.34M -13.86M -907M -14.39M -98.07M -38.79M -489M -36.41M -35.65M -1.55B | -24.97M -22.67M -20.94M -18.89M -35.67M -2.33B -37.03M -252M -99.81M -1.26B -93.7M -91.72M -3.98B |
| Net Debt | -46.16M -41.9M -38.71M -34.92M -65.92M -4.31B -68.44M -466M -184M -2.33B -173M -170M -7.35B | -21.84M -19.82M -18.31M -16.52M -31.19M -2.04B -32.38M -221M -87.28M -1.1B -81.93M -80.21M -3.48B |
Employees
13
















